REACh Principles

„No Data - No Market“   The REACh Regulation is based on the principle that substances may only be produced, placed on the market and used where sufficient data and information on the risks involved both to human health and the environment is available.   If the data required to evaluate the risks is not available the substance may neither be produced, placed on the market nor used!   Principle of Prevention   The aim is to ensure that no substances are produced, placed on the market or used which have adverse effects on human health or the environment. Therefore, risk management measures in accordance with the assessment of the risks of substances should be developed aimed at either eliminating the risk or reducing the current risk to such an extent that the remaining risk is acceptable.   Neither may the substance be produced, placed on the market or used should it prove impossible to develop adequate risk management measures to eliminate or control the risks!   Reversal of the Burden of Proof during Risk Evaluation   The central aspect of the regulation is the transfer of the risk evaluation responsibility over to the manufacturer and/or importer. This constitutes a reversal of the burden of proof compared to the former practice of deeming the authorities responsible for risk evaluation.